Sudarshan Chemical Industries Q1 FY27 Results: Profit Up, Approves Acquisition
Sudarshan Chemical Industries reported consolidated profit before tax of ₹157.4 crore for Q1 FY27. The company's Board approved the acquisition of a 70.26% stake in its step-down subsidiary, Sudarshan Colorants India Limited, as part of an internal restructuring. The Board meeting concluded on August 12, 2026.
The financial results show steady performance, and the acquisition, while strategic, is an internal restructuring and its financial impact needs further evaluation. The approval of results and acquisition is material.
The company reported positive financial results and approved a strategic acquisition, indicating growth and restructuring efforts.
Sudarshan Chemical Industries Limited announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors, in a meeting held on August 12, 2026, approved the standalone and consolidated financial results. The company reported a profit before tax of ₹157.4 crore on total income of ₹2,661.1 crore for the consolidated results. For standalone results, profit before tax was ₹74.1 crore on total income of ₹703.2 crore.
Additionally, the board accorded in-principle approval for the acquisition of 1,62,16,847 Equity Shares (70.26%) in Sudarshan Colorants India Limited, a step-down subsidiary. This acquisition is part of an internal restructuring of shareholding within the group, wherein the target company's shares will be directly held by Sudarshan Chemical Industries Limited. A Committee of Directors has been constituted to approve this acquisition, subject to regulatory compliance.
The Board Meeting commenced at 3:30 p.m. (IST) and concluded at 8:15 p.m. (IST) on August 12, 2026. The trading window for dealing in the company's securities will open on Saturday, August 15, 2026.
What to do with a filing like this
Sudarshan Chemical Industries Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Sudarshan Chemical Industries Limited. Read the original for the full detail.